Page last updated: 2024-09-05

mcc-555 and Cancer of Pancreas

mcc-555 has been researched along with Cancer of Pancreas in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baek, SJ; Imchen, T; Min, KW; Zhang, X	1

Other Studies

1 other study(ies) available for mcc-555 and Cancer of Pancreas

Article	Year
A peroxisome proliferator-activated receptor ligand MCC-555 imparts anti-proliferative response in pancreatic cancer cells by PPARgamma-independent up-regulation of KLF4. Toxicology and applied pharmacology, 2012, Sep-01, Volume: 263, Issue:2 Topics: Anilides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Gene Expression Regulation, Neoplastic; Growth Differentiation Factor 15; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Pancreatic Neoplasms; PPAR gamma; Thiazolidinediones; Up-Regulation	2012

Article

Year

A peroxisome proliferator-activated receptor ligand MCC-555 imparts anti-proliferative response in pancreatic cancer cells by PPARgamma-independent up-regulation of KLF4.

Toxicology and applied pharmacology, 2012, Sep-01, Volume: 263, Issue:2

Topics: Anilides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Gene Expression Regulation, Neoplastic; Growth Differentiation Factor 15; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Pancreatic Neoplasms; PPAR gamma; Thiazolidinediones; Up-Regulation

2012